Literature DB >> 27665457

Novel clinical and therapeutic aspects in autoimmunity.

Howard Amital1, Abdulla Watad2, Zoltán Szekanecz3.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 27665457     DOI： 10.1007/s12026-016-8856-0

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  22 in total

Review 1.  The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features.

Authors:  Mirhelen M Abreu; Adriana Danowski; Denis G Wahl; Mary-Carmen Amigo; Maria Tektonidou; Marcelo S Pacheco; Norma Fleming; Vinicius Domingues; Savino Sciascia; Julia O Lyra; Michelle Petri; Munther Khamashta; Roger A Levy
Journal:  Autoimmun Rev       Date:  2015-01-29       Impact factor: 9.754

Review 2.  Managing unwanted immunogenicity of biologicals.

Authors:  Maureen Deehan; Sandra Garcês; Daniel Kramer; Matthew P Baker; Dorothea Rat; Yvonne Roettger; Arno Kromminga
Journal:  Autoimmun Rev       Date:  2015-03-02       Impact factor: 9.754

Review 3.  On vaccine's adjuvants and autoimmunity: Current evidence and future perspectives.

Authors:  Paolo Pellegrino; Emilio Clementi; Sonia Radice
Journal:  Autoimmun Rev       Date:  2015-05-29       Impact factor: 9.754

Review 4.  Rapidly progressive diffuse systemic sclerosis after local vitamins A, D and E complex injections: literature review and report of two cases.

Authors:  Gustavo Guimarães Moreira Balbi; Ricardo Azêdo Montes; Verônica Silva Vilela; Marcella Azevedo Borges Andrade; Monisa Martins Nóbrega; Luna Azulay-Abulafia; Roberto Souto da Silva; Evandro Mendes Klumb; Roger Abramino Levy
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 5.  Type 1 diabetes associated autoimmunity.

Authors:  George J Kahaly; Martin P Hansen
Journal:  Autoimmun Rev       Date:  2016-02-20       Impact factor: 9.754

Review 6.  IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects.

Authors:  Alexandra Audemard-Verger; Evangeline Pillebout; Loïc Guillevin; Eric Thervet; Benjamin Terrier
Journal:  Autoimmun Rev       Date:  2015-02-14       Impact factor: 9.754

Review 7.  Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc).

Authors:  Gabriele Valentini
Journal:  Autoimmun Rev       Date:  2014-11-18       Impact factor: 9.754

Review 8.  The key culprit in the pathogenesis of systemic lupus erythematosus: Aberrant DNA methylation.

Authors:  Haijing Wu; Ming Zhao; Lina Tan; Qianjin Lu
Journal:  Autoimmun Rev       Date:  2016-03-10       Impact factor: 9.754

Review 9.  The clinical impact of Anti-DFS70 antibodies in undifferentiated connective tissue disease: case reports and a review of the literature.

Authors:  M Infantino; F Meacci; V Grossi; M Manfredi; F Li Gobbi; P Sarzi-Puttini; F Atzeni; M Benucci
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

10.  Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3+/IL-17A ratio and clinical course in systemic lupus erythematosus patients: a study in a Portuguese cohort.

Authors:  António Marinho; Cláudia Carvalho; Daniela Boleixa; Andreia Bettencourt; Bárbara Leal; Judite Guimarães; Esmeralda Neves; José Carlos Oliveira; Isabel Almeida; Fátima Farinha; Paulo P Costa; Carlos Vasconcelos; Berta M Silva
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.